Traversa Sergioinsider trades

In SEC Form 4 filings, Traversa Sergio is listed as Chief Executive Officer of Relmada Therapeutics, Inc. (RLMD). In the last 90 days, Traversa Sergio bought $828K of Relmada Therapeutics, Inc. (RLMD) on the open market and sold none. The largest purchase was $418K of Relmada Therapeutics, Inc. (RLMD) on Sep 9. Took part in a cluster buy; the latest at Relmada Therapeutics, Inc. (RLMD), where 2 insiders bought within 2 days, ending Sep 10.

Companies and roles

Company	Role	Transactions	Last filed
RLMDRelmada Therapeutics, Inc.	Chief Executive Officer	2	Sep 11

Cluster buys

RLMD: 2 insiders bought $1.67M between Sep 9 – Sep 10.

Form 4 historysince 2026-09-11

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RLMDRelmada Therapeutics, Inc.	Sep 10	Sep 11	P	100,000	$4.10	Purchase +$410,000	1,500,000	No	Form 4
RLMDRelmada Therapeutics, Inc.	Sep 9	Sep 11	P	100,000	$4.18	Purchase +$418,000	1,400,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.